PPGNY

Phosphagenics Ltd.

 
Sponsored ADR (1 ADS : 30 Ordinary) International Reporting
OTCQX International
Verified Company Profile 1/20/2017
Contact Info
  • Unit A8,
  • 2A Westall Road,
  • Clayton, VIC 3168
  • Australia

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Dec 31, 2016 Annual Report
CIK 0001347413
Fiscal Year End 12/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Australia
Year of Inc. 1992
Employees 18 a/o Jun 29, 2016
Company Officers/Contacts
Dr. Ross Murdoch CEO, Managing Director
Peter Lankau Managing Director
Anna Legg CFO, Company Secretary, Manager
Dr. Paul Gavin Chief Scientific Officer
Margaret Miller Executive Assistant
Company Directors
Greg Collier Chairman
Service Providers
Accounting/Auditing Firm
PricewaterhouseCoopers
Level 19 Freshwater Place
2 Southbank Boulevard
Southbank, VIC, 3006
Australia
 
Securities Counsel

Not Available
Investor Relations Firm

Not Available
Company History
  • Sponsored for OTCQX by BNY Mellon on 7/9/2007
PPGNY Security Details Other Company Securities
Share Structure
Market Value1 $15,160,406 a/o Jun 21, 2017
Authorized Shares Not Available
Outstanding Shares 1,261,965,000 a/o Dec 31, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
BNY Mellon
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
POH - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 0 (-100%)
May 31, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security